Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous ephedrine infusion vs crystalloid infusion during spinal anesthesia
DRKS00005704Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ephedrine in Drug-induced hypotension, heart failure (HF) and low cardiac output syndrome (LCOS) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Cardiac index during spinal anesthesia. Started Feb 2014; status: completed.
02
Drugs
ephedrine
03
Conditions
Drug-induced hypotensionheart failure (HF)low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on DRKS00005704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005704.